Cargando…
The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
Drug-induced liver injury (DILI) is one of the most frequent adverse clinical reactions and a relevant cause of morbidity and mortality. Hepatotoxicity is among the major reasons for drug withdrawal during post-market and late development stages, representing a major concern to the pharmaceutical in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227129/ https://www.ncbi.nlm.nih.gov/pubmed/35736496 http://dx.doi.org/10.3390/metabo12060564 |
_version_ | 1784734087191199744 |
---|---|
author | Moreno-Torres, Marta Quintás, Guillermo Castell, José V. |
author_facet | Moreno-Torres, Marta Quintás, Guillermo Castell, José V. |
author_sort | Moreno-Torres, Marta |
collection | PubMed |
description | Drug-induced liver injury (DILI) is one of the most frequent adverse clinical reactions and a relevant cause of morbidity and mortality. Hepatotoxicity is among the major reasons for drug withdrawal during post-market and late development stages, representing a major concern to the pharmaceutical industry. The current biochemical parameters for the detection of DILI are based on enzymes (alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGT), alkaline phosphatase (ALP)) and bilirubin serum levels that are not specific of DILI and therefore there is an increasing interest on novel, specific, DILI biomarkers discovery. Metabolomics has emerged as a tool with a great potential for biomarker discovery, especially in disease diagnosis, and assessment of drug toxicity or efficacy. This review summarizes the multistep approaches in DILI biomarker research and discovery based on metabolomics and the principal outcomes from the research performed in this field. For that purpose, we have reviewed the recent scientific literature from PubMed, Web of Science, EMBASE, and PubTator using the terms “metabolomics”, “DILI”, and “humans”. Despite the undoubted contribution of metabolomics to our understanding of the underlying mechanisms of DILI and the identification of promising novel metabolite biomarkers, there are still some inconsistencies and limitations that hinder the translation of these research findings into general clinical practice, probably due to the variability of the methods used as well to the different mechanisms elicited by the DILI causing agent. |
format | Online Article Text |
id | pubmed-9227129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92271292022-06-25 The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment Moreno-Torres, Marta Quintás, Guillermo Castell, José V. Metabolites Review Drug-induced liver injury (DILI) is one of the most frequent adverse clinical reactions and a relevant cause of morbidity and mortality. Hepatotoxicity is among the major reasons for drug withdrawal during post-market and late development stages, representing a major concern to the pharmaceutical industry. The current biochemical parameters for the detection of DILI are based on enzymes (alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGT), alkaline phosphatase (ALP)) and bilirubin serum levels that are not specific of DILI and therefore there is an increasing interest on novel, specific, DILI biomarkers discovery. Metabolomics has emerged as a tool with a great potential for biomarker discovery, especially in disease diagnosis, and assessment of drug toxicity or efficacy. This review summarizes the multistep approaches in DILI biomarker research and discovery based on metabolomics and the principal outcomes from the research performed in this field. For that purpose, we have reviewed the recent scientific literature from PubMed, Web of Science, EMBASE, and PubTator using the terms “metabolomics”, “DILI”, and “humans”. Despite the undoubted contribution of metabolomics to our understanding of the underlying mechanisms of DILI and the identification of promising novel metabolite biomarkers, there are still some inconsistencies and limitations that hinder the translation of these research findings into general clinical practice, probably due to the variability of the methods used as well to the different mechanisms elicited by the DILI causing agent. MDPI 2022-06-19 /pmc/articles/PMC9227129/ /pubmed/35736496 http://dx.doi.org/10.3390/metabo12060564 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Moreno-Torres, Marta Quintás, Guillermo Castell, José V. The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment |
title | The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment |
title_full | The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment |
title_fullStr | The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment |
title_full_unstemmed | The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment |
title_short | The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment |
title_sort | potential role of metabolomics in drug-induced liver injury (dili) assessment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227129/ https://www.ncbi.nlm.nih.gov/pubmed/35736496 http://dx.doi.org/10.3390/metabo12060564 |
work_keys_str_mv | AT morenotorresmarta thepotentialroleofmetabolomicsindruginducedliverinjurydiliassessment AT quintasguillermo thepotentialroleofmetabolomicsindruginducedliverinjurydiliassessment AT castelljosev thepotentialroleofmetabolomicsindruginducedliverinjurydiliassessment AT morenotorresmarta potentialroleofmetabolomicsindruginducedliverinjurydiliassessment AT quintasguillermo potentialroleofmetabolomicsindruginducedliverinjurydiliassessment AT castelljosev potentialroleofmetabolomicsindruginducedliverinjurydiliassessment |